Is Amgen A Good Stock To Buy -

In 2025, revenue grew 10% to $36.8 billion , with non-GAAP earnings per share (EPS) rising to $21.84 .

Recent moves, such as the $840 million deal for Dark Blue Therapeutics, bolster its oncology pipeline in areas like acute myeloid leukemia (AML). The Bear Case is amgen a good stock to buy

Amgen's appeal lies in its ability to generate massive cash flow while aggressively pivoting its portfolio to offset upcoming biosimilar competition. The Bull Case In 2025, revenue grew 10% to $36

The market is hyper-focused on MariTide , Amgen’s monthly-dose obesity candidate, which could disrupt the current weekly-dose market dominated by Eli Lilly and Novo Nordisk. revenue grew 10% to $36.8 billion

The company recently declared a $2.52 per share quarterly dividend, offering an attractive yield of approximately 2.9-3% .